Recent coverage of Recursion
Recent business and product coverage pulled into the profile so you can see what is happening around the company without leaving the page.
Why Recursion (RXRX) Is Up 10.8% After Deepening Citeline Partnership To Power AI-Driven Clinical Trials
Why Recursion (RXRX) Is Up 10.8% After Deepening Citeline Partnership To Power AI-Driven Clinical Trials simplywall.st
Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform
Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform Yahoo Finance
MIT and Recursion Launch an Open-Source Protein Co-Folding Model
MIT and Recursion Launch an Open-Source Protein Co-Folding Model NVIDIA
Recursion Pharmaceuticals Stock (RXRX) Opinions on Exscientia Acquisition and Partnerships | RXRX Stock News
Recursion Pharmaceuticals Stock (RXRX) Opinions on Exscientia Acquisition and Partnerships | RXRX Stock News Quiver Quantitative
Recursion Pharmaceuticals (RXRX) Is Up 6.0% After New AI Partnerships and Exscientia Acquisition Has the Bull Case Changed?
Recursion Pharmaceuticals (RXRX) Is Up 6.0% After New AI Partnerships and Exscientia Acquisition Has the Bull Case Changed? Yahoo Finance
Recursion and Google Cloud Announce Expansion of Partnership to Support Drug Discovery with Cloud and Exploration of Generative AI Technologies
Recursion and Google Cloud Announce Expansion of Partnership to Support Drug Discovery with Cloud and Exploration of Generative AI Technologies PR Newswire